RxDoctor Payments Data

Jason Roostaeian, MD

Plastic Surgery · Los Angeles, CANPI 1346491552

Payments from drug & device makers

What this record shows

This record is dominated by other: $104,375 of the $126,793 with a category attached, or 82.3%. Surgical Innovation Associates, Inc. accounts for 82.3% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2022 at $108,322 and has fallen 97.7% since, to $2,467 in 2025. Among plastic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$126,793in general payments, 2019–2025

Across 177 payments — averaging $716.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Surgical Innovation Associates, Inc.$104K
  • TELA Bio, Inc.$4K
  • Davol Inc.$3K
  • AbbVie$2K
  • Sientra, Inc.$2K
  • KCI USA, Inc.$2K
  • plus $10K from 24 others

What the payments were for

  • Consulting fees$1,7121%
  • Travel & lodging$1,1501%
  • Food & beverage$19,55615%
  • Other$104,37582%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$126,793 in reported general payments places this provider in the 95th percentile of 780 plastic surgery providers in California.

See all plastic surgery providers in California

Medicare billing

Part B allowed, 2024
$100,097
Medicare patients
95
Services billed
303

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic surgery in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →